Viewing Study NCT05347394


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-01-04 @ 9:24 PM
Study NCT ID: NCT05347394
Status: COMPLETED
Last Update Posted: 2023-05-15
First Post: 2022-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Dose Escalation Study of Oral VX-708 in Healthy Participants
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module